Abstract

Komal Wani, Mansi Narkhede and Anand Kakde*

ABSTRACT

Innovative drug administration methods are revolutionizing various scientific disciplines, including medicine, by addressing challenges related to drug delivery. The primary objective is to transport therapeutic compounds in adequate amounts to specific areas, such as melignacy and damaged muscles, while reducing toxicity and adverse effects. Diabetic retinopathy is a major concern for pharmaceutical researchers, and the evolution of an ocular drug delivery system (ODDS) is challenging due to outdated ocular solution, ointment, and suspension dosage formulas. Novel intraocular drug delivery methods based on biodegradable carriers must be developed to overcome these constraints. Ophthalmic formulations, such as eye drops and ointments, require sustained drug interaction with ocular tissue, good cornea penetration, ease of use, superior rheological characteristics, and a unirritating variation. ODDS offers benefits such as improved dosage accuracy, steady distribution, longer corneal contact duration, safety precautions, patient comfort, efficient delivery systems, quick absorption, and improved patient compliance. Due to the significant effect that diabetic retinopathy (DR) has on public health, the difficulties that come with the current therapeutic approaches, and the encouraging developments in drug delivery technology, the planned review paper on " RECENT ADVANCES FOR THE TREATMENT OF DIABETIC RETINOPATHY" is justified. A comprehensive review would address the need for consolidated knowledge, guide future research, inform clinical practice, and serve as a valuable educational resource. This evaluation would be current and beneficial to the field given the rapid improvements and the need for new knowledge.